APA (7th ed.) Citation

N, G., TA, E., JR, B., N, L., BS, M., CC, C., . . . M, S. (2025). Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study. American journal of hematology, 100(3), 511. https://doi.org/10.1002/ajh.27563

Chicago Style (17th ed.) Citation

N, Ghosh, et al. "Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study." American Journal of Hematology 100, no. 3 (2025): 511. https://doi.org/10.1002/ajh.27563.

MLA (9th ed.) Citation

N, Ghosh, et al. "Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study." American Journal of Hematology, vol. 100, no. 3, 2025, p. 511, https://doi.org/10.1002/ajh.27563.